TW279799B - - Google Patents

Info

Publication number
TW279799B
TW279799B TW083111648A TW83111648A TW279799B TW 279799 B TW279799 B TW 279799B TW 083111648 A TW083111648 A TW 083111648A TW 83111648 A TW83111648 A TW 83111648A TW 279799 B TW279799 B TW 279799B
Authority
TW
Taiwan
Prior art keywords
isopropylantipyrine
layer containing
tablet
ibusprofen
antipyretic analgesic
Prior art date
Application number
TW083111648A
Other languages
English (en)
Chinese (zh)
Original Assignee
Fujisawa Yakusin Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26416787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW279799(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Yakusin Kogyo Kk filed Critical Fujisawa Yakusin Kogyo Kk
Application granted granted Critical
Publication of TW279799B publication Critical patent/TW279799B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW083111648A 1993-12-10 1994-12-10 TW279799B (forum.php)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31080393 1993-12-10
JP7563894 1994-04-14

Publications (1)

Publication Number Publication Date
TW279799B true TW279799B (forum.php) 1996-07-01

Family

ID=26416787

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083111648A TW279799B (forum.php) 1993-12-10 1994-12-10

Country Status (13)

Country Link
US (1) US5686109A (forum.php)
EP (1) EP0812589B1 (forum.php)
JP (1) JP3168582B2 (forum.php)
KR (1) KR100347631B1 (forum.php)
CN (1) CN1094756C (forum.php)
AT (1) ATE195418T1 (forum.php)
DE (1) DE69425589T2 (forum.php)
DK (1) DK0812589T3 (forum.php)
ES (1) ES2148470T3 (forum.php)
GR (1) GR3034434T3 (forum.php)
PT (1) PT812589E (forum.php)
TW (1) TW279799B (forum.php)
WO (1) WO1995015751A1 (forum.php)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US6812985B1 (en) 1996-09-23 2004-11-02 Lg.Philips Lcd Co., Ltd. Liquid crystal display device
KR100251512B1 (ko) 1997-07-12 2000-04-15 구본준 횡전계방식 액정표시장치
JP4828707B2 (ja) * 2000-02-28 2011-11-30 武田薬品工業株式会社 固形圧縮製剤
EP1240897B1 (en) * 2001-03-14 2006-06-21 Pfizer Products Inc. Pharmaceutical tablet and process for making thereof
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
JP2003095944A (ja) * 2001-09-27 2003-04-03 Kowa Co 鎮痛剤
FR2855756B1 (fr) * 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
AU2004246837B2 (en) * 2003-06-06 2009-07-16 Ethypharm Orally-dispersible multilayer tablet
JP2008500401A (ja) * 2004-05-21 2008-01-10 アキュ−ブレイク テクノロジーズ インコーポレーテッド 複数のセグメントを含む、刻み目のある医薬錠剤
JP5259413B2 (ja) * 2005-11-18 2013-08-07 エーシーシーユー−ブレイク テクノロジーズ，インク． セグメント化した薬の剤形
EP2034953A4 (en) * 2006-06-26 2013-05-15 Capricorn Pharma Inc ORAL DISINTEGRATING LAYER COMPOSITIONS
JP2010500374A (ja) * 2006-08-08 2010-01-07 エーシーシーユー−ブレイク テクノロジーズ，インク． 複数の活性セグメントを含む薬剤の錠剤
EP2070520A1 (en) 2007-12-11 2009-06-17 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
JP2013121948A (ja) * 2011-11-07 2013-06-20 Daiichi Sankyo Healthcare Co Ltd 眠気が改善された感冒薬
JP6307874B2 (ja) * 2012-12-27 2018-04-11 大正製薬株式会社 レイヤリング粒子
JP7419057B2 (ja) * 2019-12-27 2024-01-22 ライオン株式会社 錠剤及びコーティング錠

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609752B2 (ja) * 1979-11-09 1985-03-12 東邦新薬株式会社 新規な２−アセトキシベンズアミド誘導体、その製法及びそれを有効成分とする医薬
JPS5697224A (en) * 1979-12-28 1981-08-05 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
JPS61134315A (ja) * 1984-12-05 1986-06-21 Taisho Pharmaceut Co Ltd 解熱鎮痛剤
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US5368861A (en) * 1989-10-26 1994-11-29 Nippon Shinyaku Co., Ltd. Gastric preparation with sustained release
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
AU1560692A (en) * 1991-04-08 1992-11-02 Nippon Shinyaku Co. Ltd. Capsule
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof

Also Published As

Publication number Publication date
US5686109A (en) 1997-11-11
DE69425589D1 (de) 2000-09-21
JP3168582B2 (ja) 2001-05-21
KR100347631B1 (ko) 2002-11-29
ES2148470T3 (es) 2000-10-16
CN1142766A (zh) 1997-02-12
EP0812589A4 (en) 1999-06-23
CN1094756C (zh) 2002-11-27
KR960706335A (ko) 1996-12-09
EP0812589A1 (en) 1997-12-17
DK0812589T3 (da) 2000-11-13
PT812589E (pt) 2000-11-30
WO1995015751A1 (en) 1995-06-15
GR3034434T3 (en) 2000-12-29
ATE195418T1 (de) 2000-09-15
EP0812589B1 (en) 2000-08-16
DE69425589T2 (de) 2001-01-04

Similar Documents

Publication Publication Date Title
TW279799B (forum.php)
CA2182508A1 (en) Abuse resistant tablets
CA2213987A1 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid
CA2316277A1 (en) Tablet for instant and prolonged release of one or more active substances
CA2145513A1 (en) Pharmaceutical Tablet Capable of Liberating One or More Drugs at Different Release Rates
ID26340A (id) Kapsul ganda dengan penggunaan bahan-bahan aktif dalam berbagai macam pengobatan
MX9706785A (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de la bomba de protones y un agente antiacido o alginato.
DE3567025D1 (en) Polymerisable compounds with perfluoroalkyl groups, registration layers containing them and their use in dry lithography
IT1282576B1 (it) Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
TW330217B (en) Low gauge films and film/nonwoven laminates
ES2170223T3 (es) Composicion farmaceutica que contiene hidratos de carbonato de lantano seleccionados.
CA2185893A1 (en) Multilayered controlled release pharmaceutical dosage form
CA2214033A1 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
RU93058536A (ru) Орально вводимая форма лекарственного средства на основе пантопразола
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
DE69227914D1 (de) Wirkstoffabgabevorrichtung mit zwei geschwindigkeiten
CA2082768A1 (en) Diagonal veneer laminate
IL108682A (en) Tube for the storage and distribution of a flavoured or scented product which contains water
USD357742S (en) Electrotransport drug delivery system
DE3581006D1 (de) Feste orale arzneiformen mit gestaffelter wirkung zur verabreichung von wirkstoffen mit geschwuere erzeugender nebenwirkung.
USD292358S (en) Measuring dispenser for coffee and other granular substances
CA2400550A1 (en) Packaging for a plaster containing active ingredients
HU9402637D0 (en) Multiple package for the simultaneous administration of two or more liquids in a preparation
CA2012538A1 (en) Packaging film
FI812131A7 (fi) Farmaseuttinen seos, jolla on antiflogistinen, antipyreettinen ja analgeesinen vaikutus.